Mariusz A Wasik

Publication Activity (10 Years)

Years Active: 2015-2023
Publications (10 Years): 4

Top Topics

Immune Response

Top Venues

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Qian Zhang, Johnvesly Basappa, Hong Y Wang, Selene Nunez-Cruz, Cosimo Lobello, Shengchun Wang, Xiaobin Liu, Seble Chekol, Lili Guo, Amy Ziober, Reza Nejati, Alex Shestov, Michael Feldman, Jerry D Glickson, Suzanne D Turner, Ian A Blair, Chi Van Dang, Mariusz A Wasik
Chimeric kinase ALK induces expression of NAMPT and selectively depends on this metabolic enzyme to sustain its own oncogenic function. Leukemia (2023)
Katherine Sullivan-Reed, Monika Maria Toma, Malgorzata Drzewiecka, Margaret Nieborowska-Skorska, Reza Nejati, Adam Karami, Mariusz A Wasik, Tomasz Sliwiński, Tomasz Skorski
Simultaneous targeting of DNA polymerase theta and PARP1 or RAD52 triggers dual synthetic lethality in homologous recombination-deficient leukemia cells. Molecular cancer research : MCR (2023)
Vijay G Bhoj, Dimitrios Arhontoulis, Gerald Wertheim, James Capobianchi, Colleen A Callahan, Christoph T Ellebrecht, Amrom E Obstfeld, Simon F Lacey, Jan J Melenhorst, Farzana Nazimuddin, Wei-Ting Hwang, Shannon L Maude, Mariusz A Wasik, Adam Bagg, Stephen Schuster, Michael D Feldman, David L Porter, Stephen A Grupp, Carl H June, Michael C Milone
Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy. Blood 128 (3) (2016)
Michael T Werner, Chen Zhao, Qian Zhang, Mariusz A Wasik
Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target. Blood 129 (7) (2016)
Mariusz A Wasik
IL-13 as a novel growth factor in CTCL. Blood 125 (18) (2015)